Last Updated : July 14, 2004
Details
FilesGeneric Name:
Treprostinil sodium
Project Status:
Complete
Therapeutic Area:
Pulmonary arterial hypertension (NYHA Class III and IV patients)
Manufacturer:
Northern Therapeutics Inc.
Brand Name:
Remodulin
Project Line:
Reimbursement Review
Project Number:
SR0011-000
Submission Type:
Initial
Indications:
Pulmonary arterial hypertension (NYHA Class III and IV patients)
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list.
Files
Last Updated : July 14, 2004